Switching from Multiple Insulin Injections to a Fixed Combination of Degludec and Liraglutide in Patients with Type 2 Diabetes Mellitus: Results from the Simplify Study After 6 Mon...

por Martinka, Emil, Dravecká, Ingrid, Tkáč, Ivan
Publicado 2023

Prevalence of Positivity for Diabetes-Associated Autoantibodies in Individuals with Type 2 Diabetes and Their Further Characterisation: Cross-sectional Study from Slovakia

por Rončáková, Mariana, Davani, Arash, Mikušová, Veronika, Ságová, Ivana, Novodvorský, Peter, Martinka, Emil
Publicado 2023

Current Level of Glycemic Control and Clinical Inertia in Subjects Using Insulin for the Treatment of Type 1 and Type 2 Diabetes in the Czech Republic and the Slovak Republic: Resu...

por Brož, Jan, Janíčková Žďárská, Denisa, Urbanová, Jana, Brabec, Marek, Doničová, Viera, Štěpánová, Radka, Martinka, Emil, Kvapil, Milan
Publicado 2018

Prevalence and epidemiological characteristics of patients with diabetic retinopathy in Slovakia: 12-month results from the DIARET SK study

por Ondrejkova, Marta, Jackuliak, Peter, Martinka, Emil, Mokan, Marian, Foley, James, Fabkova, Jana, Gecik, Karol, Tvrda, Iveta, Helbich, Miroslav, Gajdosova, Monika
Publicado 2019

Expert Opinion on the Therapeutic Use of the Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide: a Central/Eastern European Perspective

por Haluzík, Martin, Flekač, Milan, Lengyel, Csaba, Taybani, Zoltán, Guja, Cristian, Mihai, Bogdan-Mircea, Cerghizan, Anca, Martinka, Emil, Kovacs, Gabor, Kempler, Péter
Publicado 2020

Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review

por Janež, Andrej, Guja, Cristian, Mitrakou, Asimina, Lalic, Nebojsa, Tankova, Tsvetalina, Czupryniak, Leszek, Tabák, Adam G., Prazny, Martin, Martinka, Emil, Smircic-Duvnjak, Lea
Publicado 2020

Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)

por Schernthaner, Guntram, Lehmann, Roger, Prázný, Martin, Czupryniak, Leszek, Ducena, Kristine, Fasching, Peter, Janež, Andrej, Karasik, Avraham, Kempler, Peter, Martinka, Emil, Shestakova, Marina V., Duvnjak, Lea Smirčić, Tankova, Tsvetalina
Publicado 2017

SGLT2 inhibitors in T2D and associated comorbidities — differentiating within the class

por Schernthaner, Guntram, Drexel, Heinz, Moshkovich, Evgeny, Zilaitiene, Birute, Martinka, Emil, Czupryniak, Leszek, Várkonyi, Tamás, Janež, Andrej, Ducena, Kristine, Lalić, Katarina, Tankova, Tsvetalina, Prázný, Martin, Smirčić Duvnjak, Lea, Sukhareva, Olga, Sourij, Harald
Publicado 2019

Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes

por Schernthaner, Guntram, Shehadeh, Naim, Ametov, Alexander S., Bazarova, Anna V., Ebrahimi, Fahim, Fasching, Peter, Janež, Andrej, Kempler, Péter, Konrāde, Ilze, Lalić, Nebojša M., Mankovsky, Boris, Martinka, Emil, Rahelić, Dario, Serafinceanu, Cristian, Škrha, Jan, Tankova, Tsvetalina, Visockienė, Žydrūnė
Publicado 2020